Benjamin Van Tassell, PharmD
Virginia Commonwealth University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Benjamin Van Tassell, PharmD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:59 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05177822 · Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart FailureVirginia Commonwealth University · active not recruiting · Heart Failure · principal investigator
- Ph2NCT03797001 · Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2Virginia Commonwealth University · completed · Heart Failure, Systolic, Inflammation · principal investigator
- N/ANCT03323840 · Pilot for a Community Pharmacy Service Model: Impact of a Pharmacist Monitored Patient Blood Pressure ReadingsVirginia Commonwealth University · completed · Hypertension · principal investigator
- Ph2NCT02173548 · Interleukin-1 Blockade in HF With Preserved EFVirginia Commonwealth University · completed · Heart Failure With Normal Ejection Fraction · principal investigator
- Ph1/Ph2NCT01936896 · Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial InfarctionVirginia Commonwealth University · completed · Acute Myocardial Infarction · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Prevention of heart failure with IL-1 blockade: a mechanistic studyR01AG076360 · NIA · VIRGINIA COMMONWEALTH UNIVERSITY · PI Antonio Abbate, Georgia Thomas · fiscal years 2022 to 2026Named on NCT05177822
- Interleukin-1 blockade in heart failure with preserved ejection fractionR34HL118348 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Antonio Abbate, Benjamin W Van Tassell · fiscal years 2014 to 2015Named on NCT02173548
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.